The classification posts. The 483 behind it doesn't.

A firm watch built around warning letters is watching downstream of the record that actually moves first. FDA scores every inspection it closes — No Action Indicated, Voluntary Action Indicated, or Official Action Indicated — and publishes that score in a database anyone can query for free, no FOIA request, no waiting on a records office. The document a warning letter is actually built from — the Form 483 an investigator hands the firm at the closing meeting — is a different record entirely, and it is not sitting in that same free database. Conflating the two costs a watch its earliest public signal.

What the classification database actually is

FDA’s Inspection Classification Database records the final outcome of a closed inspection as one of three values. No Action Indicated means the facility was found in an acceptable state of compliance, typically with no Form 483 issued at all. Voluntary Action Indicated means the inspection found objectionable conditions FDA judged the firm capable of correcting on its own, usually with a Form 483 issued and no further agency action planned. Official Action Indicated means the facility was found in an unacceptable state of compliance — serious enough that FDA may pursue further regulatory action, of which a warning letter is one option among several, not a guaranteed next step. The database updates weekly, is downloadable directly, and requires no request to anyone.

The document behind the classification is a different animal

Section 704(b) of the Federal Food, Drug, and Cosmetic Act — 21 U.S.C. § 374(b) — requires the FDA investigator, at the close of an inspection, to give the firm’s management a written report of any conditions or practices observed that, in the investigator’s judgment, indicate a violation. That written report is the Form 483. It exists for every inspection where an observation was made, whether the case ultimately closes VAI or OAI. None of that makes it public by default. FDA posts a subset of 483s through its FOIA electronic reading rooms, selected by public interest or by a prior request that already cleared review — FDA Radar’s own sources page lists 483s as not covered for exactly this reason. The classification the 483 led to is a free lookup. The 483 itself is a records request with its own processing time.

A closed inspection has a verdict long before it has a paper trail anyone outside the firm has read.

Two different documents, two different clocks

That gap matters because the two records answer different questions on different schedules. The classification database tells you, this week, whether a given establishment’s most recent inspection came back clean, correctable, or serious — a signal available before any warning letter has been drafted, and in two of the three outcomes, one that may never come. The 483 tells you what the investigator actually saw, in their own words, and that document can take weeks to request and receive even after the free database has already told you the inspection went badly. Treating “no warning letter yet” as “nothing happened at this facility” misses the classification that was sitting in public view the whole time.

The practice

A firm watch built on warning letters alone is watching the record that arrives last, if it arrives at all. The classification database is worth checking against the same firm names a warning letter watch already tracks — your own manufacturing sites, your contract manufacturers, a supplier you rely on — normalized the same way a firm name has to be normalized anywhere else in this record: case folded, punctuation stripped, legal suffix dropped, nothing fuzzier than that, because a wrong match here names the wrong facility just as certainly as it would in a warning letter join. An OAI result is worth treating as a leading indicator — reason to watch that name more closely, not reason to conclude a letter is coming, since the database itself does not commit to that outcome.

Whether a given OAI classification should change how you qualify a supplier, or what it implies for a site you depend on, is a judgment for whoever owns that risk file, on the current record — this is a description of what two adjacent FDA records do and don’t tell you, never a determination about a specific facility. The Inspection Classification Database is not currently one of the sources FDA Radar ingests; the warning letters we do carry are, by definition, downstream of exactly the classification this piece describes.